A neomorphic syntaxin mutation blocks volatile-anesthetic action in Caenorhabditis elegans

Area of Science:

• Neuroscience and Pharmacology
• Genetics and Molecular Biology

Background:

• The molecular targets and mechanisms of general anesthesia, particularly volatile anesthetics (VAs), remain largely unknown.
• Previous research suggested both lipid and protein targets for VAs, but lacked definitive in vivo evidence implicating specific molecules.
• Identifying genes that regulate sensitivity to clinical concentrations of VAs is crucial for understanding anesthetic action.

Purpose of the Study:

• To identify genes and molecular targets involved in regulating sensitivity to volatile general anesthetics (VAs) using a genetic approach.
• To investigate the role of the neuronal syntaxin gene and its interacting proteins in mediating anesthetic effects.

Main Methods:

• Screening of existing mutant strains of the nematode Caenorhabditis elegans for altered sensitivity to volatile anesthetics (isoflurane and halothane).
• Pharmacological characterization of anesthetic effects on synaptic transmission in wild-type and mutant strains.
• Analysis of syntaxin allelic variation and its impact on anesthetic sensitivity.

Main Results:

• A mutation in the neuronal syntaxin gene conferred dominant resistance to isoflurane and halothane in C. elegans.
• Other mutations in syntaxin and its binding partners (synaptobrevin, SNAP-25) resulted in hypersensitivity to VAs.
• The resistant syntaxin mutation blocked the presynaptic reduction in cholinergic transmission caused by halothane and isoflurane, suggesting a direct interaction.

Conclusions:

• The findings challenge non-specific membrane perturbation theories of anesthesia, supporting a direct molecular target model.
• Syntaxin and its associated proteins are identified as candidate presynaptic targets for volatile anesthetics.
• Genetic variation in syntaxin significantly influences sensitivity to general anesthetics, providing a novel avenue for research.